Back to Journals » Cancer Management and Research » Volume 14

The Blood Biomarkers of Thyroid Cancer [Corrigendum]

Authors Wang W , Chang J, Jia B, Liu J

Received 31 December 2021

Accepted for publication 31 December 2021

Published 5 January 2022 Volume 2022:14 Pages 49—50

DOI https://doi.org/10.2147/CMAR.S356638



Wang W, Chang J, Jia B, Liu J. Cancer Manag Res. 2020;12:5431–5438.

On page 5431, the authors have advised that the affiliation for the first author, Weiran Wang, is incorrect.

The updated authorship and affiliations are as follows:

Weiran WangJingtao ChangBaosong JiaJing Liu2

1Shanxi Medical University, The First Clinical Medical School, Taiyuan, Shanxi, People’s Republic of China; 2First Hospital of Shanxi Medical University, General Surgery Department, Taiyuan, Shanxi, People’s Republic of China

Read the original article

Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.